Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited ("OKYO" or the "Company") today announces that Bernard Denoyer has been appointed as a non-executive director of the Company with...
Synergy Pharmaceuticals Announces Completion of Sale to Bausch Health PR Newswire NEW YORK, March 6, 2019 NEW YORK, March 6, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the...
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. PR Newswire LAVAL, Quebec, March 6, 2019 LAVAL, Quebec, March 6, 2019 /PRNewswire/ -- Bausch Health Companies...
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health PR Newswire NEW YORK, March 1, 2019 NEW YORK, March 1, 2019 /PRNewswire/ -- Synergy Pharmaceuticals...
Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. PR Newswire LAVAL, Quebec, Feb. 26, 2019 Bausch Health and Synergy to Seek Bankruptcy Court Approval of Sale on March 1...
Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets PR Newswire NEW YORK, Feb. 26, 2019 NEW YORK, Feb. 26, 2019 /PRNewswire/ -- Synergy Pharmaceuticals...
Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc. PR Newswire LAVAL, Quebec, Dec. 12, 2018...
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets Company Initiates Voluntary Chapter 11 Process to Effectuate Sale; Secures Commitment for DIP...
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its...
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
